no desc

Prof. Luís Henrique W. Gowdak A new* solution to revive the metabolic power of the heart in patients with chronic coronary syndrome​

Background Vimeo Live Event

About the event

The Clarify registry revealed that 33.9% of patients with angina symptoms when included in the registry, were still experiencing symptoms 5 years after, reflecting the need for innovative and effective anti-anginal therapy. 1

In this video, Prof. Luís Henrique W. Gowdak, cardiologist and investigator from Brazil, introduces us to VASTAREL OD 80mg, a brand new solution for the treatment of symptomatic patients with chronic coronary syndrome.

VASTAREL OD 80mg has a unique metabolic mode of action, allowing to optimize the use of O2 and to increase the production of ATP, while improving contractility at the cardiac level. 2,3
* prolonged-release formulation

1. Mesnier J et al; CLARIFY Investigators. International observational analysis of evolution and outcomes of chronic stable angina: the multinational CLARIFY study. Circulation. 2021;144⁷:512-23 2. Lopaschuk GD & Stanley WC. Glucose metabolism in the ischemic heart. Circulation. 1997;95²:313-5​ 3. Hu B et all. Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials. Clin Cardiol. 2011;34⁶:395-400
Background Vimeo Live Event

Don't miss our next events!

Subscribe to our newsletter to receive invitations to upcoming events

You can unsubscribe at any time by clicking on the link in our emails.
SERVIER CENTRAL AMERICA AND THE CARIBBEAN, S.A.Edificio Dream Plaza, Costa Del Este, Ciudad de Panamá, Panamá+507-301-0227Todo el contenido de este sitio web, es sólo para los profesionales de la salud y un uso interno del evento.
LogoCopyright © 2022 Servier University by SERVIER CENTRO AMÉRICA Y EL CARIBE, S.A.